Voyager Therapeutics Stock Market Value
| VYGR Stock | USD 5.75 0.06 1.05% |
| Symbol | Voyager |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Voyager Therapeutics. If investors know Voyager will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Voyager Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.66 | Revenue Per Share 2.953 | Quarterly Revenue Growth 4.338 | Return On Assets 0.0157 | Return On Equity 0.1022 |
The market value of Voyager Therapeutics is measured differently than its book value, which is the value of Voyager that is recorded on the company's balance sheet. Investors also form their own opinion of Voyager Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Voyager Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Voyager Therapeutics' market value can be influenced by many factors that don't directly affect Voyager Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Voyager Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Voyager Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Voyager Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Voyager Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Voyager Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Voyager Therapeutics.
| 01/03/2023 |
| 12/23/2024 |
If you would invest 0.00 in Voyager Therapeutics on January 3, 2023 and sell it all today you would earn a total of 0.00 from holding Voyager Therapeutics or generate 0.0% return on investment in Voyager Therapeutics over 720 days. Voyager Therapeutics is related to or competes with Fate Therapeutics, Sana Biotechnology, Caribou Biosciences, Arcus Biosciences, Karyopharm Therapeutics, X4 Pharmaceuticals, and Hookipa Pharma. Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platfor... More
Voyager Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Voyager Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Voyager Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.23 | |||
| Information Ratio | (0) | |||
| Maximum Drawdown | 36.72 | |||
| Value At Risk | (7.03) | |||
| Potential Upside | 9.47 |
Voyager Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Voyager Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Voyager Therapeutics' standard deviation. In reality, there are many statistical measures that can use Voyager Therapeutics historical prices to predict the future Voyager Therapeutics' volatility.| Risk Adjusted Performance | 0.0096 | |||
| Jensen Alpha | (0.07) | |||
| Total Risk Alpha | (0.16) | |||
| Sortino Ratio | (0) | |||
| Treynor Ratio | (0) |
Voyager Therapeutics Backtested Returns
Currently, Voyager Therapeutics is moderately volatile. Voyager Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0136, which indicates the firm had a 0.0136% return per unit of risk over the last 3 months. We have found thirty technical indicators for Voyager Therapeutics, which you can use to evaluate the volatility of the company. Please validate Voyager Therapeutics' Semi Deviation of 4.92, risk adjusted performance of 0.0096, and Coefficient Of Variation of 81032.38 to confirm if the risk estimate we provide is consistent with the expected return of 0.0761%. Voyager Therapeutics has a performance score of 1 on a scale of 0 to 100. The entity has a beta of 3.11, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Voyager Therapeutics will likely underperform. Voyager Therapeutics right now has a risk of 5.59%. Please validate Voyager Therapeutics maximum drawdown, skewness, as well as the relationship between the Skewness and day typical price , to decide if Voyager Therapeutics will be following its existing price patterns.
Auto-correlation | 0.24 |
Weak predictability
Voyager Therapeutics has weak predictability. Overlapping area represents the amount of predictability between Voyager Therapeutics time series from 3rd of January 2023 to 29th of December 2023 and 29th of December 2023 to 23rd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Voyager Therapeutics price movement. The serial correlation of 0.24 indicates that over 24.0% of current Voyager Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.24 | |
| Spearman Rank Test | 0.21 | |
| Residual Average | 0.0 | |
| Price Variance | 1.4 |
Voyager Therapeutics lagged returns against current returns
Autocorrelation, which is Voyager Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Voyager Therapeutics' stock expected returns. We can calculate the autocorrelation of Voyager Therapeutics returns to help us make a trade decision. For example, suppose you find that Voyager Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Voyager Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Voyager Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Voyager Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Voyager Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Voyager Therapeutics Lagged Returns
When evaluating Voyager Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Voyager Therapeutics stock have on its future price. Voyager Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Voyager Therapeutics autocorrelation shows the relationship between Voyager Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Voyager Therapeutics.
Regressed Prices |
| Timeline |
Pair Trading with Voyager Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Voyager Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Voyager Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Voyager Stock
The ability to find closely correlated positions to Voyager Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Voyager Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Voyager Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Voyager Therapeutics to buy it.
The correlation of Voyager Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Voyager Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Voyager Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Voyager Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Voyager Stock Analysis
When running Voyager Therapeutics' price analysis, check to measure Voyager Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Voyager Therapeutics is operating at the current time. Most of Voyager Therapeutics' value examination focuses on studying past and present price action to predict the probability of Voyager Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Voyager Therapeutics' price. Additionally, you may evaluate how the addition of Voyager Therapeutics to your portfolios can decrease your overall portfolio volatility.